Amedeo Smart

Free Medical Literature Service


 

Amedeo

Depression

  Free Subscription

Articles published in
J Neurochem
    September 2024
  1. KAVAKBASI E, Sampson E, Mills NT, Hori H, et al
    Inflammation-stratified augmentation of vortioxetine with celecoxib: Results from a double-blind, randomized, placebo-controlled trial in major depressive disorder.
    J Neurochem. 2024;168:1817-1825.
    >> Share

    July 2024
  2. HOJGAARD K, Kaadt E, Mumm BH, Pereira VS, et al
    Dysregulation of circadian clock gene expression patterns in a treatment-resistant animal model of depression.
    J Neurochem. 2024 Jul 5. doi: 10.1111/jnc.16172.
    >> Share

    June 2024
  3. GONZALEZ PM, Jenkins AR, LaMalfa KS, Kangas BD, et al
    Chronic ecologically relevant stress effects on reverse-translated touchscreen assays of reward responsivity and attentional processes in male rats: Implications for depression.
    J Neurochem. 2024 Jun 24. doi: 10.1111/jnc.16157.
    >> Share

    March 2024
  4. BREMSHEY S, Gross J, Renken K, Masseck OA, et al
    The role of serotonin in depression-A historical roundup and future directions.
    J Neurochem. 2024 Mar 13. doi: 10.1111/jnc.16097.
    >> Share

  5. ZHAO Y, Wan J, Li Y
    Genetically encoded sensors for in vivo detection of neurochemicals relevant to depression.
    J Neurochem. 2024 Mar 11. doi: 10.1111/jnc.16046.
    >> Share

  6. FARINHA-FERREIRA M, Magalhaes DM, Neuparth-Sottomayor M, Rafael H, et al
    Unmoving and uninflamed: Characterizing neuroinflammatory dysfunction in the Wistar-Kyoto rat model of depression.
    J Neurochem. 2024 Mar 2. doi: 10.1111/jnc.16083.
    >> Share

    January 2024
  7. ABE Y, Erchinger VJ, Ousdal OT, Oltedal L, et al
    Neurobiological mechanisms of electroconvulsive therapy for depression: Insights into hippocampal volumetric increases from clinical and preclinical studies.
    J Neurochem. 2024 Jan 18. doi: 10.1111/jnc.16054.
    >> Share

    August 2023
  8. PIECHOTA M, Hoinkis D, Korostynski M, Golda S, et al
    Gene expression profiling in whole blood stimulated ex vivo with lipopolysaccharide as a tool to predict post-stroke depressive symptoms: Proof-of-concept study.
    J Neurochem. 2023;166:623-632.
    >> Share

    July 2023
  9. LEWIS V, Rodrigue B, Arsenault E, Zhang M, et al
    Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders.
    J Neurochem. 2023;166:10-23.
    >> Share

    March 2023
  10. CHENG S, Wang W, Zhu Z, Zhao M, et al
    Involvement of brain-derived neurotrophic factor methylation in the prefrontal cortex and hippocampus induced by chronic unpredictable mild stress in male mice.
    J Neurochem. 2023;164:624-642.
    >> Share

    November 2022
  11. EDWARDS MJ, Wilson GC, Keitsch S, Soddemann M, et al
    Molecular targets of endothelial phosphatidic acid regulating major depressive disorder.
    J Neurochem. 2022;163:357-369.
    >> Share

    July 2022
  12. DU Y, Shi Y, Wang X, Song H, et al
    Hippocampal Semaphorin 3B Improves Depression-like Behaviours in Mice by Upregulating Synaptic Plasticity and Inhibiting Neuronal Apoptosis.
    J Neurochem. 2022 Jul 26. doi: 10.1111/jnc.15680.
    >> Share

  13. KOZLOWSKA U, Nichols C, Wiatr K, Figiel M, et al
    From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.
    J Neurochem. 2022;162:89-108.
    >> Share

    August 2021
  14. WANG W, Wang R, Jiang Z, Li H, et al
    Inhibiting Brd4 alleviated PTSD-like behaviors and fear memory through regulating immediate early genes expression and neuroinflammation in rats.
    J Neurochem. 2021;158:912-927.
    >> Share

    July 2021
  15. LUO S, Hou Y, Zhang Y, Feng L, et al
    Bag-1 mediates glucocorticoid receptor trafficking to mitochondria after corticosterone stimulation: Potential role in regulating affective resilience.
    J Neurochem. 2021;158:358-372.
    >> Share

    January 2021
  16. GRUNDER G, Cumming P
    Serotonin and amyloid deposition: A link between depression and Alzheimer's disease?: An Editorial Highlight on "Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Abeta production and related pathology in a mouse model of Alzheimer's
    J Neurochem. 2021 Jan 18. doi: 10.1111/jnc.15269.
    >> Share

    October 2020
  17. SUENTO WJ, Kunisawa K, Wulaer B, Kosuge A, et al
    Prefrontal cortex miR-874-3p prevents lipopolysaccharide-induced depression-like behavior through inhibition of indoleamine 2,3-dioxygenase 1 expression in mice.
    J Neurochem. 2020 Oct 23. doi: 10.1111/jnc.15222.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016